Protecting Groups M.S.
Protecting Groups M.S.
Protecting Groups M.S.
'
\T:
1. Introduction
"
Me02C
mMe0
N-CO,Me
MeO&
CHO
"
N-C02Me
OMOM
!???#.+
Me02C
2
Scheme 1. Protecting group problems in the synthesis of mitomycin analog
FR-900482 by S. Danishefsky et al. [ 5 ] . MOM = methoxymethyl, Bzl = benzyl.
nied by decomposition of the aziridine. To avoid this problematic situation, the hydroxyl groups in 2 were not protected as
methyl ethers but rather as benzyl and methoxymethyl ethers.
Unfortunately, after this seemingly innocuous"I alteration in
the protecting group pattern, the selective FeC1,-mediated
cleavage of the oxirane failed owing to the higher lability of the
newly introduced ether functions. The authors were forced to
find an entirely new reagent to complete the synthesis.'6]
Another unexpected protecting group problem appeared during the total synthesis of taxol, again by Danishefsky et aL1'] The
advanced intermediate 3 was converted into the epoxide 4, but
the robust tot-butyldimethylsilyl (TBDMS) ether could not be
removed in the next steps (Scheme 2). Thus the TBDMS in 3
was replaced by the more labile triethylsilyl (TES) ether. Compound 5 was converted into the corresponding epoxide 6, which
was then successfully transformed into the complex natural
2057
REVIEWS
OBzl
OBzl
iEtL
0
OAc
OBzI
>
0
'
tiixol
h> S l);inlslieS\k!
REVIEWS
n=1,2
isopropylidene
cyclopentylidene
cyclohexylidene
benzylidene
pmethoxybenzylidene
opdirnethoxybenzylidene
0
x
R R'
O x 0
R R '
1,3-dioxane
1,3-dioxolane
The cleavage of protecting groups by acid-mediated hydrolysis is one of the best established methods in protecting group
chemistry and forms one of the central pillars of the subject.
Nevertheless. only those protecting groups that can be removed
under sufficiently mild (but not too mild) conditions find widespread use.
tetrahydropyranyl
(ThP)
rnethoxymethyl
(MOM)
methoxyethoxyrnethyl
(MEW
benzyloxyrnethyl
rnethylthiomethyl
(BOW
(MTM)
2059
REVIEWS
pGiq
horvaeetate can be removed selectively in the presence of acetate, and acetate can be cleaved in the presence of pivalate.
Basic cleavage of amides to liberate amines is only seldom
used on account of the generally harsh conditions required.
The phthaloyl group is one exception; it can be cleaved with
hydrazine under mildly basic conditions. Again, it should be
noted that the silyl ethers can be removed by basic hydrolysis
(however, see Section 2.3).
X=O,NH
PG =
felt-butyl
0 Bu)
felt-butyloxycarbonyl
adarnantyloxycarbonyl
(Adoc)
tO K /
NO*
benzyloxycarbonyl
(Z, Cbz)
para-methoxybenzyloxycarbonyl
para-nitrobenzyloxycarbonyl
(MOZ)
(4-NO,-Z)
Scheme 5. Examples of acid-labile protecting groups that are cleaved with formation of stabilized cations.
X=O,NH
PG =
9-fluorenylmethoxycarbonyl
2-(phenylsulfonyl)ethoxycarbonyl
(Fmoc)
R-0-PG
PG =
acetyl
benzoyl
(Bz)
pivaloyl
(Piv)
2060
'I
Silyl protecting groups can be cleaved by treatment with fluoride ion under conditions that affect nearly no other functionalities. They thus make up a n essential chapter in protecting
group chemistry (Scheme 8). Variation of the substituents on
silicon allows modification of their stability towards acids and
bases, as well as the selectivity of the cleavage with fluoride ion
(see Section 3.2.2 and Scheme 37). A simple rule of thumb
holds-the greater the steric demand, the higher the stability.
Alcohols are typically protected as trialkylsilyl ethers; the order
of stability for the ethers is TMS < TES < TBDMS < TIPS[161
z thexyl. For particularly challenging cases, a further level of
fine-tuning can be achieved with, for example, isopropyldimethylsilyl,[171 diisopropylmethylsilyl,['81 and diethylisopropylsilyl (DEIPS)[191groups. I,3-Diols can be masked as
silanediyl derivatives (see also Scheme 44) or by introduction of
the tetraisopropyldisiloxane-l,3-diyl(TIPDS) group. Silyl groups
are rarely used for the protection of esters and amines due to the
high lability of the resulting derivatives (the STABASE protecting group[201for amines is an exception, see Scheme 8). For
this purpose, trialkylsilylethyl esters and carbamates have been
Angew. Chenr. In!. Ed. Engl. 1996. 35, 2056-2083
REVIEWS
R-X
X=O,NH
= peptide, nucleoside,
nucleotide. carbohvdrate.
plactarn antibiotic [2'-231
1
IDenicillin G acvlase I
0
R.oz/Si,
Me
1 ,Me
peptide, lipopeptideI'[
Me
trirnethylsilylethox ycarbonyl
(Teoc)
X=NH,O
trirnethylsilylethyl
(TMSE)
trirnethylsilylethoxyrnethyl
( S W
acetyl esterase
0
0
RKO-~(~e)3
I
0
~r
butyrylcholine esterase
M,e ,Me
,Si
R-N\
Si
I \
Me Me
RKO-
R = pepttde, glycopeptide
llipasej
STABASE
di-t-butylsilanedryl
(DTBS)
1 ,I ,3,3-tetraisopropyldisiloxane-l,3-diyl
(TIPDS)
R = carbohydrate [212']
I
Scheme 8. Examples of protecting groups that are cleaved with fluoride ions
R'OKMe
"I
In many cases the selective removal of different acyl protecting groups from amines and alcohols and the targeted deblocking of carboxylic acids under mild conditions is most readily
achieved with biocatalysts. Enzymes typically function in the
p H range 5 - 9 and at room temperature; they may display a
high specificity for the structures they recognize and the reactions they catalyze, and at the same time they may tolerate a
wide range of substrates. Thus enzymes enable the targeted removal of protecting groups (which may in principle also be
removed by classical chemical methods) under mild conditions
and with a chemo- and regioselectivity that is hardly, if at all,
possible by classical chemical techniques. Although the development of enzymatic protecting group techniques has been intensively studied only in the last few years. a number of interesting
enzyme-labile protecting groups have been developed for organic synthesis (Scheme 9). Thus, for example. the phenylacet
(PhAc) amide['31 and the 4-acetoxybenzyloxycarbonyl (AcOz)
have been used as enzyme-labile protecting functions for amino groups, and carboxylic acids can be selectively
dernasked through enzyme-mediated cleavage of heptyl[251and
choline esters.[261Hydroxyl groups protected as the acetate,
benzoate. butyrate, and even pivalate can be liberated enzymatically.["
221 In this way such conversions can be carried out in
carbohydrate, steroid,
nucleoside, phenol ['12'2J
REVIEWS
OMe
Br, CI
Y = H, Br. CI
ScI1c111c 10 '-Haloelll!l
p r o l c c l l l l ~gr<Iup, 111'11
i.11,
IhC
cIc;I\cd h\
rcdUCIIOI1
DDQ
or
CAN
Zinc is the preferred electron donor. but electi-ochemical methods are also successfully used.
The reduction of. for instance. ester protecting groups with
complex hydrides. reagents that also will attack ii pivalate ester.
is rarely used. owing to thc poor selectivity ofthese reagents. A n
exception worth mentioning is the regioselcctive opening of benxylidene acetals in carbohydi-ate
(Scheme 1 1 ). The
OMe
,OAc
(OAc
,OAc
,OAc
1 ..i-dithiancs can be hydrolyticallq regenerated easily by treatnicnt with stoichiomcti-ic amounts of Hg". Ag'. Cu". or TI"' salts
o r alternativelq bq 1-caction with other electi-ophiles o r by oxidution o f thc sulfur (see Section 7.6).
Catalytic iunotints of Khl. I]-". and Pd" complexes and even
Pd -C suffice for the removal of protecting groups containing
the ally1 group. Thus. ally1 cthel-s in carbohydrates and peptides
can be selectively isomerized to the acid-labile prop-l -enyl system through the action ofcalalytic quantities of Pd C 01- Kh'.
o r Ir" complexes. Hydrolysis of this g r o ~ i pis achieved under
inild conditions. (Schemc 1 3 ) . T h t allyloxycarbonyl ( Aloc)
or Pd C
The choice of oxidation-labile protecting groups is vci-y l i m i t ed. The 4-methoxybenzyl ( M p m ) and the more labile 2.4dimethoxybenzyl (Dmpm) ethers have proved their worth 21s
reagents in the synthesis o f complex molecules. Both o f these
functions are easily removed under mild conditions with
dichlorodicyanoquinone ( D D Q ) or with cerium(rv) ammonium
nitratc (CAN) (Scheme 12). or under acidic conditions (sec SCCtion 2.1.1).
I t is also worth mentioning that S.S-acetals of carbonyl compounds, such as 1.3-dithianes. can he cleaved after oxidation of
the sulfur (Scheme 12).
2062
R = alkyl, acyl
cod=
Stable Form
oxidation
REVIEWS
f
~9Labile Form
OdR base
,s=o
Me0
Cleavage
Me
Me,s=o
\\
rnethylthioethyl (Mte)
HN~
HN~
(1,3-dithiane-2-yl)methoxycarbonyl (Dmoc)
R-0-PG
PG =
2-brornoethylester
onitrobenzyl
(OW
o-hydroxystyrydirnethylsilyl
choline ester
(Cho)
Z-oxo-l,2-diphenylethyl
(Desyl)
REVIEWS
cally stable precursor is introduced, which is converted into an
activated intermediate directly before cleavage. In this case no
additional reagent, such as a base or a nucleophile, is required
in order to remove the protecting groups. The activated intermediate itself carries a reactive functional group, typically a nucleophile, which intramolecularly attacks the bond to the
blocked function and thus causes the cleavage of the protecting
group. Several examples of this technique are presented in
Scheme 16. Thus, reduction of the nitro-substituted aromatic
3-(oNitrophenyl)acetyl
or -propionyi
X=O,NH
n=1,2
4-azidobutvrvl
4-oxoacyl
2-chloracetyl
0 NH,
REVIEWS
Orthogonal Stability
YA BY C?
-1base-labileJ
A
/VNH
Modulated Lability
A"
ASA
mNH
mNH
WWLT-rf
X l f
c,
. I
'I
DMTo@
CN
w
Y Y ?
x y z
A"
y v z
'
Scheme 17. Orthogonal stability and moldulated lability as basic concepts for the
development of protecting group strategies.
deblockings extend the synthesis significantly. These disadvantages do not exist if one uses a set of protecting groups of similar
but modulated stability. In practice, a combination of the two
strategies is often employed, in which the earlier stages rely more
heavily on orthogonal stability and in the latter stages the concept of similar lability is more important.
These two fundamental strategies can be augmented by auxiliary strategies, including:
- the earliest possible unification of a protecting group pattern
- the introduction of "stand-ins"
- the use of protecting groups to direct reactions.
,Cost
BU
Pd-C,
MeOH/ THF
+
+
vb-
%HI\,
Fmoc
, ..,
MI\,
5"C, quant.
Fmoc
I Dolastatin 3
] = 11
Scheme 19. The Combination of acid-labile, base-labile, and reduction-labile protecting groups in the synthesis of a precursor of dolastatin 3 (11) by R. C Kelly
et al. [38a]
2065
REVIEWS
selectively protected glutamic acid derivative 7 the a-benzyl ester
was selectively removed by hydrogenolysis and then the desired
bisthiazole unit was constructed. Acid-mediated cleavage of the
y-tert-butyl ester in 9 opened up the possibility of converting the
y-carboxyl group of glutamic acid into the amide. In both steps
the Fmoc group remained intact. This group can be removed
under basic conditions, if required, and the amino acid N-terminus can be
Among the classical combinations of protecting groups is the
simultaneous use of acid-labile acetals for the protection of carbony1 groups or 1,2-diols, base-labile esters, and reductively
cleavable benzyl groups. This strategy is often used, particularly
in the field of carbohydrate chemistry, as illustrated by the synthesis of the dimeric Lewis" antigen described by R. R. Schmidt
et al. (Scheme 20).[391In this case, the isopropylidene group of
R
CF3C02H
CHzC12
98%
/
p
A
\
O-CO2Me
OBz
OBzHo
12
AcO
I OAc
,&$-O$O
H
HO
OBzHo
ride 15 by acidic hydrolysis. This made possible repeated glycosylation with the trisaccharide unit 14, leading to the complete
octasaccharide 16. Finally, all the protecting groups were successively removed from 16.
As demonstrated in this example, acetals are commonly employed as temporary protecting groups, whereas benzyl and acyl
protecting functions are preferred as permanent protecting
groups. When all such groups are removed to give the target
compound, the acyl groups are typically removed before the
benzyl ethers, in order to minimize steric hindrance in the final
heterogeneous catalytic hydrogenolysis. For this reason, it can
be advisable to exchange benzyl for acyl protecting groups as
early in the synthesis as possible (see Section 3 . 3 ) .
Examples of alcohols protected as acyclic 0,O-acetals are
given in Schemes 40,45, and 5O.Oxidation-labile and acid-labile
protecting groups can also be advantageously combined. In the
example in Scheme 41 the oxidatively cleavable (but also acidlabile) Mpm and Dmpm ethers were combined with an acidlabile dimethyl acetal.
OBz
BF3.Etz0, CH&/
hexane, 71%
13
AcO
15
64%
AcO
I OAc
M e p O B z l
OAc
AcO
16
MeO.,,
OTBC
1) CF3COzH,CH,CI,
95%
2) NaOMe, MeOH; Ac,O, pyr, 87%
3) HS-(CH&-SH. py / Hz0; AcZO, py, 93%
4)Pd-C, H, MeOH: NaOMe, MeOH, quant
Galp(l-4)GlcNAcS(1-3)Galp(l-4)GlcNAc~(l-3)Gal~(1-4)Glc~1-O)-R
Fuca(1-3)
17
Fuca(1-3)
Scheme 20. Synthesis of the dimeric Lewis" antigen by R. R. Schmidt et al. [39].
2066
HFI CH CN
REVIEWS
oxidants D D Q and CAN (see Section 2.3), which are used for
the oxidative cleavage of the Mpm and Dmpm groups, can in
the worst case attack only the most labile silyl ethers such as the
T M S group. which is seldom used in any case due to its high
hydrolytic lability.
An illustration of the use of Mpm ethers in concert with
various silyl ethers is provided by the synthesis of the
immunosuppressant FK506 (21) by S. L. Schreiber et al.
(Scheme 21 ) . I 4 ' ' Two hydroxyl groups are masked as substituted benzyl ethers and four others as different silyl ethers in the
advanced intermediate 18. Oxidation with DDQ cleaved the
alkoxybenzyl ethers selectively, and the hydroxyl group thus
liberated was then oxidized with Dess- Martin periodinane to
give the corresponding diketone 19. Of the various silyl groups
in 19 (for a discussion of their relative stabilities see Section 3.2.2). the most labile was removed by treatment with acid
and the selectively demasked hydroxyl group was then oxidized
to give triketone 20 (see Section 3.4 for the strategy of masking
carbonyl groups by the temporary introduction of hydroxyl
groups as "stand-ins"). The synthesis was completed by the
simultaneous cleavage of the remaining silyl groups.
The combination of Mpm and silyl ethers also proved its
worth in the synthesis of the immunosuppressant rapamycin by
K. C. Nicolaou et al. (Scheme 22).[421In this case, the hydroxyl
-+ '+
0
MpmO
MpmO
OTBDMS
Me
Me
OMe
Me
22
Me
23
TIPS
Morn0
Mom0
OTBDMS
24
TIPS
29
I ) HFI Py.97%
2) (COCI),, DMSO
NEt,, 97%
H-Phe-Thr-OAII
25
EEDQ, 81%
TIPS
30
____)
26
TIPS
quant.
OH
DDQ, CHCI, I HO
,
25"C, 1h, 98%
Me
Me
6MeMe
31
Me
27
__I)
TIPS
0
*
\
1 -
Me
Me
OMeMe
Me
28
Scheme 22. Sections of the synthesis of the immunosuppressant rapamycin by
K. C. N~colaouet iil. [42].
Angrpi . Clioi? Inr Ed En,ql 1996, 35, 2056-2083
32
Scheme23. Application of allyl esters in a glycopeptide synthesis by H. Kunz
et a]. [43]. EEDQ = ethyl-2-ethoxy-I .2-d1hydroquinoline-l-carboxylate.
2067
REVIEWS
acetates of the carbohydrate moiety were attacked under these
conditions.
The especially mild conditions for the cleavage of allyl esters
were also used to advantage by S. Danishefsky et al. in the
synthesis of the immunosuppressant r a p a m y ~ i n [(Scheme
~~I
24).
Attempts to activate the carboxyl group in the advanced intermediate 33 prior to a condensation reaction resulted in lactonization at the tertiary OH group of the tetrahydropyranyl
H
[Pd2(dba)J, PPh,, CHCI,
n C4H9NH2I HC02H
50"C, l h
K
11
33
Me.,,&
OMe
Me
0'
polymer-bound DNA
All
Scheme 25. Application of allyl protectlng groups in the synthesis of oligonucleotides by R. Noyori et al. [45]. dbd = dibenzyhdeneacetone.
35
dl.
[44]
41
Scheme 26. Cleavage of an ally1 carbonate in the synthesis of a taxol analog by
S . Blechert et 81. 1461.
OAll
1) CF~COZH
thioanisole
HO.,
0
81-90%
I
42
OBzl
45
OBzl
OBzl
44
parts orthogonality to protecting groups which, under classical deblocking methodology, would have similar or even inverted lability.
Both principles were utilized in the chemoenzymatic synthesis
of the S-palmitoylated and S-funesylated C-terminal lipo-
@
choline
A l o ~ - C y s - M e t - G l y - O - ~ ( ~ ~ ) ~esterase
I
Bra
S
-
Aloc-Cys-Met-Gly-OH
I
S-pal
"---Y-46
Pal
47
H-Leu-Pro-Cys-OMe
48 F./'
REVIEWS
49
Aloc-Cys-OH
I
50 '-Pal
H-Met-Gly-Leu-Pro-Cys-OMe
I
51
.F
' ar
53
1) AcOZ-Met-Gly-OH
AcO
carbodamide
2) lipase
I
48
54
Hep
AcO
A
base M
PH
37%,
7.076%
Z-ker-Thr-Ala-OHep
I
'-Far
2-Ser-OH
OAC
4~0%
AcHN
H-Leu-Pro-Cys-OMe
OAC
cAcHN
O q
?I
Z-Ser-Thr-Ala-OH
1
___t
F
.' ar
4
iipase
0
M e P o e o d
AcOZ
A c O B o
Act) 'OAc
Acb b A c
O O e O d L e u - P r o - C y s - IO M e
0
A c O S o
55
AcO
56
OAc
AcO+
AcHN
H-Pro-Pro-Ala-OHep
Leu-Pro-Cys-OMe
I
52 S
I
Z- Ser -Thr-Ala-Pro-Pro-Ala-OHep
I
AcHN
57
Far
carbodiirnide, 62%
AcO
OAc
2069
REVIEWS
fragment of a tumor-associated antigen that appears on the
surface of human breast cancer cells.
Selective N-terminal cleavage of a phenylacetoxybenzyloxycarbonyl (PhAcOZ) urethane group (analogous to the AcOZ
group) in 0-glycopeptides was accomplished by action of penicillin G a c y i a ~ e(Scheme
[ ~ ~ ~ 30). The enzymatic cleavage of this
pow
penicillin G acylase
pH 7.5, RT, 78%
Nd-orBu
v
58
PhAcOZ
AcO
PhAcOZ-Ser-Pro-OH
H-Ser-Of Bu
(Ac),GlcNAc
PhAcOZ-Ser-Pro-Ser-Of
Bu
I
I
* (Ac)~GIcNAc GlCNAC(AC),
(Ac)3GlcNAc
condensation
59
60
H-Ser-Pro-Ser-Of
Bu
I
I
(Ac)~GIcNAc G~cNAc(Ac)~
penicillin G acylase
pH 7.5, RT, 74%
61
Aloc-Ser-Pro-Thr-Ser-Pro-Ser-Of
__t
___)
O=P-OAII
Bu
62
Scheme 30. Use of the enzyme-labile PhAcOZ group in the synthesis of a hexdpeptide sequence of a partially processed RNA polymerase by H. Wdldmann et al. [49].
RT = room temperature.
urethane protecting group in 58 yielded 59, which was condensed with a further glycosylated dipeptide to give 60. The
N-terminal protecting group in 60 was removed enzymatically
in a selective manner, and the peptide 61 thus liberated was
finally converted into the phosphorylated and glycosylated peptide conjugate 62, a characteristic sequence of a partially processed RNA polymerase. In the enzymatic transformations described in Schemes 29 and 30, no undesired attack on the acetate
esters in the carbohydrates was observed, and neither b-elimination of the carbohydrate moiety nor anomerization of the glycosidic bonds take
The stereoselectivity of enzyme-mediated reactions can also
be used advantageously for the preparation of specifically functionalized and protected synthetic intermediates. An example of
this is the desymmetrization of the meso diacetate 63 in the
enantioselective synthesis of the indole alkaloid (-)-anthirin
(66) by G. Lesma et al.[511(Scheme 31). Diester 63 was convert-
O-Ac
lipase from
~porcine
~
pancreas
96%; 99% ee
OH
0-Ac
---+
ti
u
65
66
2070
(AC)~GICNAC GlCNAC(AC),
OAll
67
1I
hv, 82%
Scheme 32. Application of a photolabile o-nitrobenzyl protecting group in the synthesis of calichearnicin y: by K. c. Nicolaou et al. [65].
the natural product towards the coupling reaction with the aglycone, the anomeric center of the terminal carbohydrate part of
the fully protected intermediate 67 had to be liberated. The
o-nitrobenzyl ether function proved to be a suitable protecting
group. Due to its high stability, it could be introduced at an
early point in the synthesis and remained intact even under
drastic conditions such as treatment with methoxide, tetrabutylammonium fluoride, bromine, and diisobutylaluminum hydride. However, it was easily cleaved from 67 in high yield by
photolytic conditions, under which the oxime group, the glycosidic bond, the thioester, the Fmoc group, and the silyl ether all
remained intact.
The rate and selectivity of the photochemical deblocking is
also an integral part of the "caging" technique used in biological
studies[661(Scheme 33). In this context a inactive substrate such
as 69 having a photolabile protecting group is introduced into a
biological system, for example, a cell. The protecting group is
removed by an intense flash of light and the active compound,
in this case 70, is thereby liberated. The advantage of this
method is the precise triggering of the deprotection and liberaAnpen-. Chem. Int. Ed. E n d 1996, 35. 2056-20X3
OH
HO-P11.0
Ic-AMP
70
:93
Me-0
tion of the active species, making pharmacokinetics measureable, even for fast processes. The prerequisite for the use of the
"caging" technique is that the photodecomposition products
have minimal toxicity. The required excitation wavelength and
intensity should also not damage the cell. The photolabile protecting group most frequently employed in synthesis is the o-nitrobenzyl group. Since the photochemical cleavage of this species leads to the production of the toxic o-nitrobenzaldehyde,
other photolabile groups such as l-pyrenylethyl[671and the benzoin
are commonly used for biological applications
(see Scheme 33). An exception was described by W. Mantele et
al.,[691who monitored the progress of a reaction by following
the decomposition of an mi-nitro intermediate by IR spectroscopy.
Although photochemically cleavable protecting groups offer
many advantages, their use is restricted since the substance to be
deblocked may not itself contain any photoexcitable functional
groups. For this reason this protecting group strategy was not
widely applied for a long time. In more recent developments, for
example the establishment of anchor groups in combinatorial
chemistry (see Section 5), photolabile protecting groups may
play an increasingly important role.
5% CF&O2H I
CHC13,0C,
72
71
1 ) OsO, NalO,
2) NaOH, H20 I
dioxane
AcO
HO
74
73
In
the
0
m O ' E - O t
\
CF3CH2OHI
HCI. pH 3.5
Bu
lllr
75 Trt
Bpoc
Bpoc-Ot
Ot Bu
Bu
76
s
'
coupling
___t
'I O f B u
i Or Bu
p Ot Bu
BU
s?
S-Acm
Boc
77
Bu
H-------rOt
'
S-Acm
Boc
I
S-Acm
S-Acm
I
Boc
90% aq.
CF3CHzOH
60C
coupling
78
s-s
Boc
OtBu
.
1 ) 95% aq.
CF3C02H
2) 12/AcOH
Ot Bu
79
s-s
I
__t
O H
0-Me
Bpoc~-Ot
:v3
-
?
?
s-s
'
OH
OH
80
Scheme 35. Use of acid-labile protecting groups with modulated lability in the
synthesis of human insulin by P. Sieber et al. [71].
2071
REVIEWS
varying lability-the tert-butyl ester and the Bpoc and trityl (Trt)
groups. First the trityl group was removed selectively in the presence of the Bpoc group, which is likewise very acid-sensitive. After
extension of the B chain (76 -+77),the Bpoc group was selectively
removed. The A chain was completed by coupling 78 with a
similarly Boc-protected peptide. All the tert-butyl protecting
groups in 79 were then simultaneously cleaved. After the cysteine side chain was deblocked, ring closure provided insulin 80.
While the synthesis shown in Scheme 35 proves that this
methodology can be quite successful, it has not found widespread use in peptide chemistry due to the potential of losing
protecting groups required later in the synthesis. Owing to their
greater reliability, orthogonal protecting strategies are generally
preferred.
The modulated based-lability of two urethane protecting
groups was used by K. C. Nicolaou et al. in the synthesis of a
calicheamicin-dynemicin hybrid1721(Scheme 3 6 ) . The 2-fluo-
R-O-SiRS3
Actdolysis:
Basic solvolysis:
R',Si:
= t BuPh,Si
(!ir;,').
various silyl ethers under acidic and basic conditions. (The order
of the cleavage rates on treatment with fluoride ions is similar.)
As a consequence of this range of activities, silyl ethers with
modulated solvolytic activity are now commonly used in synthesis.
tert-Butyldimethylsilyl (TBDMS) ethers can be cleaved with,
for example, tetrabutylammonium fluoride (TBAF), while the
cleavage of the more stable triisopropylsilyl (TIPS) and the terfbutyldiphenylsilyl (TBDPS) protecting groups requires solutions of HF in pyridine, acetonitrile, or even water.
These clear differences in reactivity were employed by
Danishefsky et al. in the synthesis of the immunosuppressant
r a p a m y ~ i n (Scheme
~ ~ ~ ] 38). When intermediate 83, which con-
I ) TBAFI HOAc
2) Dess-Martin
periodinane
Me..,&
e
/
;
-
M
Me
OTlPS
Me OMe Me Me OTBDMS
83
Me
1) TiCl,(Oi Pr)
2 ) HF 1 PY
Me
82
Scheme 36. Use of amino protecting groups of differing lability in the synthesis of
a calicheamicin-dynemicin hybrid by K . C. Nicolaou et al. 1721.
84
Me
I Rapamycin 1 = 85
Scheme 38. Use of silyl protecting groups of modulated lability in the synthesis of
rapamycin (85) by S Danishefsky et al. [44].
Anpew. Chem. l n t . E d Enyl. 1996.35. 2056-2083
REVIEWS
in the synthesis of FK505[411(Scheme 21). Macrocycle 19 contains TIPS, TBDMS, and TES protecting groups, of which only
the TES group was removed by treatment with aqueous trifluoroacetic acid, allowing the selective oxidation of only one of
the four hydroxyl groups.
R. A. Holton et al. took advantage of the varying lability of
silyl ethers towards both bases and different sources of
fluoride ions in the synthesis of the antitumor agent tax01"~~
(Scheme 40). Thus, treatment of 89 with acetic acid cleaved only
F c c o
TIPSO
91
92
86
TIPSO
94
93
0
TASF: (Et2N)$
Me
Me
OMe Me Me
.,
88
Scheme 39. Use ofsilyl protecting groups of modulated lability in the synthesis of
rapamycin by K . C. Nicolaou et al. [42].
Of the five silyl protecting groups present in 86, only the TES
ethers were cleaved by HF/pyridine. Thus the selective oxidation of the liberated secondary hydroxyl groups to give the
corresponding carbonyl groups could be carried out. The remaining, more stable silyl ethers were cleaved by treatment with
H F in CH,CN/H,O, and the synthesis was subsequently concluded by Pdo-mediated coupling of the two vinyl iodides.
The differing acid sensitivity of silyl ethers allowed S.
Schreiber et at. to selectively deblock an advanced intermediate
A n g w . (%em i n l Ed Engl. 1996. 35, 20.56 -2083
0
Me,SiF,
Scheme 40. Use of silyl protecting groups of modulated lability in the synthesis of
taxol by R. A. Holton et al. 1731.
the TMS ether; the other acid-labile groups, the BOM acetal
and the other silyl groups, remained intact. After transformation of 90 into the oxetane 91, the TES group was selectively
removed by treatment with HF/pyridine. The central eightmembered ring was oxygenated as required in the position adjacent to the free hydroxyl group. Finally, the remaining TBDMS
protecting group was removed with the reagent TASF (see
Scheme 40; this conversion failed with TBAF) to allow the attachment of the side chain.
REVIEWS
'
-,
HO&
o>
:OH
1''
'
0
".,
96
&"'*
MpmO
"OH
DDQ
CH,CI,
RT
"0
1."
"OH
0
97
_.
(MethynolidelE 98
"OcN
0
DDQ=
CI
CN
0
Scheme 41. Selective oxidative cleavage of the Dmpm group in the presence of the
Mpm group in the synthesis of methynolide (98) by 0. Yonemitsu et al. [74,75].
PDC = pyrrdinium dichromate. RT = room temperature.
8-
TBDMSO
(Ph),F TBDMSO.,,
OTBDMS
,..OTBDMS
TBDMSO
C o \ ' " Z M S
CH(SEt),
103 OMMTr
/'
102
~ O T B D M S
'"OTBDMS
OTBDMS
OTBDMS
HO
Me0
TBDMSO
t'
0
Noc
TBDMSO
OTBDMS
OTBDMS
OTBDMS
M p m q oM~
:,pm
'"OTBDMS
Me0w
OAc
&
OTBDMS
' OAc
OTBDMS
"
'.OTBDMS
m
~
the late stages of a synthesis, for example after successful construction of the molecular framework. First, the molecule must
be stable under all of the conditions used for deblocking. This
stipulation must be made in the selection of protecting groups
for each subunit in the whole molecule. It is thus possible that
2074
1) - 5)
REVIEWS
MOM?
@O+
MOMO
OLi
116
117
Me
MgBr,. 0.24%.
MO#cozMoM
\
/
Me
Me
,t Bu
MOMO
OMe
/
\
36h
15% (4 steps)
OH
t Bu
OTES
I I ,
112
HO
OH
119
TBDMSO
t Bu
113
1) DDQ, CH&
2 ) Dess-Martin Deriodinane
Me
0 ,tBu
f Bu
TBDMSO
114
OH
= 115
Scheme44. Synthesis of cytovaricin (115) by D. A. Evans et al. [78]. DEIPS =
diethylisopropylsilyl. TCEM = trichloroethoxymethyl.
Scheme 45. Use of a single type of protecting group in the synthesis of dynemicin
by S. Ddnishefsky et al. [79]. MOM = methoxymethyl.
116 and 117 were fused to give compound 118 with three MOM
acetal protecting groups, from which the sensitive natural
product 119 was liberated.
The protecting group pattern of an advanced intermediate
was changed by K. C. Nicolaou et al. in the synthesis of
calicheamicin y, [651 (Scheme 46). The complex glycoside 123
was formed from the predominantly acyl-protected unit 120 and
the intermediates 121 and 122. After the coupling, the acetates
were transformed into silyl ethers, which were cleaved in the
same step as the silyl ethers originating from 121 and 122 by
treatment with HF/pyridine in almost quantitative yield.
In the synthesis of the glycosphingolipid Gb, (130). K. C.
Nicolaou et a1.[801swapped the reduction-sensitive benzyl ethers
for the base-labile acetates and thus unified the pattern of protecting groups (Scheme 47). Because the gdlactosylfluoride 125
carried benzyl groups, its coupling with the partially deblocked
glycosyl acceptor 126 yielded the trisaccharide 127 predominantly as the a-anomer. Intermediate 126 carried acyl protecting
groups, guaranteeing a high degree of P-selectivity in the introduction of the sphingosine group (see also Section 3.5). At the
stage of trisaccharide 127 the benzyl protecting groups were
2075
REVIEWS
-v
removed by hydrogenolysis and the hydroxyl groups thus liberated were immediately protected as acetates. The complete
trisaccharide unit thus contained exclusively base-labile acyl
protecting groups, which, at the end of the synthesis, were removed simultaneously in high yield. This strategy also proved to
be very effective in the construction of the trimeric Lewis"
nonasaccharide.[*'I
AcO
01
Meofi
TESO Me
oMe
123
.4
Fmoc
Et'MeO
PY
THF/ CHzCIz (5:l)
96%
124
EfMeO
125
126
.OMpm
127
1) NBS, HF/ py, 89%
2) Hz, Pd(OH)z/C
3) Ac~O,DMAP, py
91% (2 steps)
HC(0H)ZCOzH
AcOH I CHzCIz
70%
128
?)Me
?H
PivO
129
HNK(CHZ),&H3
Pglycoside
NaOMe, MeOH
90%
HO
"'OMe
OMe
130
Scheme 47. Unification of the protecting group pattern in the synthesis of the
glycosphingolipid Gb, (130) by K. C. Nicolaou el al. [Sl].
2076
133
Scheme 48. Application of 1.3-dithiane and dimethyl acetal protecting groups in
the synthesis of the immunosuppressant FK506 by S . L. Schreiber et al. [41].
An.qew. Chem. Int. Ed. Engl. 1996, 35, 2056--2083
Protecting G r o w Chemistry
yields. Only dethioacetalization employing a hypervalent iodine
reagent as a mild oxidant gave satisfactory results. Even so, the
aldehyde thus liberated was not isolated directly in the free state.
but rather as the dimethyl acetal 132. This very sensitive compound yielded 133 with the free aldehyde group after transacetalization with glyoxylic acid under mildly acidic conditions.
This approach is practically identical to that employed by T. K.
Jones et al. in the synthesis of FK506.[821
The example just given illustrates that, despite the effectiveness of thioacetals and acetals as protecting groups, the conditions necessary for their removal often hinder their use. 1,3-Di01s can also be protected as silylene derivatives, which are useful
replacements for the acid-labile acetals (see 114 in Scheme 44).
When such choices are not available, a completely different
tactic must be used.
In one increasingly popular alternative strategy a stand-in
is introduced for the required functional group. In the case of a
carbonyl group, a masked alcohol can be used, which can be
deprotected and subsequently oxidized to give the required aldehyde o r ketone. Although a further protecting group must be
introduced in following this strategy, many more masking
groups are established for the hydroxyl function.
This methodology is illustrated by the synthesis of FK506 by
S. Schreiber et al.14]sketched out in Scheme 21. The very sensitive and reactive tricarbonyl unit in 20 was constructed right at
the end of the synthesis by the deprotection and oxidation of the
corresponding hydroxyl groups. The successive deblocking and
oxidation prevented the formation of mixtures of products resulting from incomplete oxidation. TES- and Mpm-protected
hydroxyl groups were employed as the stand-ins for the carbony1 groups. while the hydroxyl groups found in the final
product (20) were masked as TIPS and TBDMS ethers.
Similarly, in the synthesis of rapamycin by S. Danishefsky et
al.441(Scheme 38) a t a step close to the end of the synthesis, one
of the three protected hydroxyl groups in 83 is selectively deblocked and oxidized to give a carbonyl group.
D. A. Evans et al. also used this strategy in the synthesis of
cyt~varicin~]
(Scheme 44). The hydroxyl group to be oxidized
in 113 was present as the Mpm ether, whereas all other alcohols
were blocked as silyl ethers. After cleavage of the benzylic protecting group with DDQ, the required carbonyl group was
formed and finally the silyl groups removed. This approach was
necessary because the hemiacetal formed in the last step is very
sensitive (see Section 3.3.).
REVIEWS
Me
Me
Me
134
PG = BzI
PG = TBDMS
+
135 : 136 = 2:l
135 : 136 = 5:l
OH
PGO
Me
135
PGO
B
OH
z
Me
Me
136
137
138
ratio of 135 and 136 formed from the addition of propenylrnagnesium bromide to the aldehyde 134 was dependent upon the
type of ether function present in 134. When the secondary hydroxyl group was protected as its benzyl ether, this ratio was
2 : l ; however, the corresponding silyl ether led to a 5 : l ratio
of 135 and 136. The silyl group hindered the formation of a
1,3-chelate leading to anti-136 and favored the development of
a Felkin-Anh transition state leading to the s.vn-diol. The
diastereomeric ratio could be increased further by manipulation
of the protecting groups. The mixture of 135 and 136 was converted to the acetonides 137 and 138. An unfavorable 1,3-diaxial
interaction of the ketone with one of the methyl groups of the
acetal protecting group came into play in 138, which meant that
138 could be equilibrated to the more stable 137 by treatment
with K,CO, in methanol.
BOM, MOM, and MEM ethers are typically used as chelating
protecting groups (see Section 2.1 .I .). Thus, for example,
M. Isobe et al. employed the directing effect of a M E M group
for the stereoselective construction of a precursor to mayt a n ~ i n (Scheme
~~]
50). In the reaction of 139 with methyllithium, the oxygen atoms of the protecting group complex the
lithium cation and thus force the attack of the organometallic
reagent onto the Re side of the double bond in the vinyl sulfone.
The directing effect of protecting groups is typically used in
the synthesis of oligosaccharides, where the course of the glyco-
?+ lM:\Tp
Me3Si> S02Ph
0-07
<o!.ii-Me
Ph02S
Me
Ph
SiMe,
139
SO2Ph
Ph
Me
Scheme 50. Directing influence of the MEM protecting group in the synthesis of a
precursor of maytansin by M. Isobe et al. [85].
2077
REVIEWS
sylation can be affected. In glycosyl donors such as 140
(Scheme 51) the ester function in the 2-position shields the underside of the glycosyl cation 142 formed during the glycosylation reaction. Thus, the glycosyl acceptor 143 attacks from
above to form the /I-glycoside 144.[861If the 2-position of the
CICH2C00
140
CICH2C00
68%
142
yo
Me
145
82%
146
BzlO ,oBZl
B z l 0 BzlO
9 ; % 4&
147
AcHN OBzl
OAc
a-glycoside
1
148
B
0O
II,
++I
1
G
OBzl
OH
Tetrasaccharide
glycosyl donor is not blocked by an acyl group capable of neighboring group participation, as is the case in the benzyl-protected
donor 145, then the a-glycoside, in this case 147, is preferentially
formed. This directing effect was used highly effectively by
B. Fraser-Reid et al. in the synthesis of 147, en route to the
tetrasaccharide characteristic of the human blood group B.
A further example is given in the preparation of the Gb, glycolipid by K. C. Nicolaou et al. sketched in Scheme 47.
The type of protecting group determines not only the stereochemical course of glycoside synthesis, but also affects the reactivity of the glycosyl donor. Since esters are better electron acceptors than ethers, the formation of glycosyl cations is less
favored from an acyl-protected glycosyl donor like 140 than
from an alkyl-protected donor such as 145. The nucleophilicity
2078
Of Bu
Boc-Ser-Ser-Ser-Asn-Tyr-Cys-Asn-Gln-Met-Met-Lys-Ser
1) (CHzO),, 98%
21
H,N-Cys-Arg-Asp-Lys-Thr-Leu-Asn- Arg
40
149
Acm
f B u f B u O t B u f B u tBu Boc t 6 u
OfBu
NPS-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-OH
7
ffpy0
HO
2) LDA, NCC02Me
, N-NMe
\
'
ao
CN)
MeN
151
C0,Me
K0 NMe
152
15
150
0
Acm.
MepN?
H
NPS:
153
Scheme 52. The "minimal protection" tactic In the synthesis of the S-protein of
ribonuclease A (11 40 fragment 149) by R. Hirschmann and D. F. Veber el al. [89]
and the "maximum protection'. tactic in the synthesis of glucagon (7-15 fragment
150) by E. Wiinsch et al. [90].
Scheme 53. Use of the triazone protecting group in the synthcsis of strychnine by
L. E. Overman et at. [92].
H-Phe-Trp-Gly,
!*No
H
laccase, p~ 4,
154
H-Phe-Trp-Gly,N,N
o2
H-Phe-Trp-Gly-OH + N2
155
Scheme 54. Enzymatic cleavage of phenylhydrazides from peptides by A. N.
Semonov et al. [93].
5. New Developments
Most of the protecting groups discussed in Sections 2 through
4 have been known for some time. Their usefulness has been
demonstrated in a multitude of complex syntheses and they can
be considered to be well-established[lO. (this conclusion cannot yet be drawn for the enzyme-labile protecting groups). Nevertheless, the development of new protecting group techniques
and the improvement of existing methods continues to be the
subject of intensive research in organic synthesis. The following
trends can be distinguished from the large number of new developments.
'
New developments on protecting groups with modulated reactivity have been described for silyl ethers, in particular (see
Section 2.3). but new acid-labile groups have also been successfully developed and applied. An example is the triazone protecting group for amines developed by s. Knapp et al.,[911which
blocks two N -H positions and can be easily cleaved with dilute
acid. This protecting group was essential in studies by L. E.
Overman et
on the synthesis of the strychnine alkaloids,
as illustrated by the synthesis of strychnine itself (Scheme 53). In
the precursor 151 the amino group of the aniline was masked as
a triazone. which, after a domino sequence consisting of Mannich reaction and aza-Claisen rearrangement, could be removed
from 152, enabling the subsequent ring closure to give 153.If the
tert-butylurethane (Boc) group or a pivalinamide is used in
place of the triazone, the selective cleavage is not successful.
The application of biocatalysts has given the area of orthogo-
der acidic conditions, with the help of benzylidene-l,2-dibromide under basic conditions[961is also a valuable alternative.
2079
REVIEWS
OMe
OM.
EtS
E'S
EtS
Me0
Hod
Ho OH
156
HC(OMe)3
OBzl
:;,LZCO2H*
OMe
157
EtS
Me?
Me0
HO&
-(' F
Roosph+
I
166
OMe
1) NIS, CF,CO,H
2) AcOH / HzO
3) HP, Pd-C
Ho OH
161
159
R O - O167
O O F
K k!JNQ
a
0
pH=9-10
HN-0
162
165
~ o ~ o ~ o J -
-l"."c
HOG;:
AgC104
~
169
S
---t
h
NISP/ TfOH
(AsO-rf)
- o ~
171
Scheme 57. Construction of oligsaccharides by T. Ogawa et al. [99] using orthogonal activation. NIS = N-iodosuccinimde, TfOH = trifluoromethanesulfonic acid.
were converted into reactive glycosyl donors with N-iodosuccinimide and trifluoromethane sulfonic acid o r with silver(1) trifluoroacetate. The configuration of the anomeric center of the
fluorosugar remained stable under these conditions. However,
when bis(cyclopentadieny1)hafnium dichloride and silver(1)
perchlorate were used, only the glycosyl fluorides 167 and 171
were activated. This switchable activation and direct glycosylation allows a rapid and elegant synthesis of oligosaccharides.
The strategy is highly efficient, and it can be expected that further combinations of protecting groups capable of orthogonal
activation will find use.
tions peptide derivatives such as 162 react at the urethane function to form 1-acylbenzimidazolin-2-ones such as 163. These
activated compounds can then be coupled directly with amino
acid esters and peptide esters. A further example is the use of
n-pentenyl groups in carbohydrate chemistry'981 (see Section
3.5, Scheme 51). In 140 and 145 the anomeric center is protected
as a pentenyl ether. Treatment with N-iodosuccinimide and triethylsilyl triflate converts the stable, protected 140 and 145 into
the activated glycosyl donors 141 and 146, respectively.
If the principle of converting protecting groups to activating
groups can also be applied to doubIy orthogonal systems, then
2080
REVIEWS
work of S. Fodor et al.,['o'l who have combined modern protecting group chemistry with photolithographic methods for the
parallel synthesis of oligopeptides and oligonucleotides on spatially well-defined regions of a solid support (Scheme 58). The
-lhVl
YG YG YG YG
NH NH NH NH
\\\\\\\\
photodeprotection
YG YG
NHz NHZ NH NH
\\\\T\\\-
A-PG
The development of more efficient protecting group techniques, relying, for example, on differences in reactivity between
similar functional groups (see Section 4) and on new reagents
with alternative reactivities, stabilities, and selectivities, continues to be the focus of attention (see Section 5 ) and will certainly
lead to new protecting group strategies. Protecting group chemistry will thus continue to provide organic synthesis with great
impetus in the future and open up new possibilities.
The basis and motivation ,for this review was research carried
out at the Universities of Mainz, Bonn, und Kurlsruhe aimed at
developing and establishing enzymatically cleavable protecting
groups (see re6 / 2 1 ] ) . Active participants in this work were (in
alphabetic order) :Peter Braun, Alain CottP, Stephanie Gabold,
Simone Glonisda, Axel Heuser, Yolker Jungmunn, Thomas
Kappes, Bruno Klaholz, Karsten Kuhn, Edgar Niigele, Torsten
Pohl, Armin Reidel, Jorg Sander, Bernd Sauerbrei, Michael
Schelhaas, Dagmar Sebastian, and Paul Stiiber. We are grateful
to the Deutsche Forschungsgemeinschaft, the Fonds der Chemischen Industrie, the Bundesministeriurnfur Bildung und Forschung,
BASF AG, Boehringer Mannheim GmbH, and Degussa AG ,for
funding our research.
Received: December 15. 1995
Revised version March 11. 1996 [A14SIE]
German version: Angew. Chem 1996, 108, 2192-2219
Translated by Dr. D . Macqudrrie, York (UK)
[i] K. C . Nicolaou, E. J. Sorensen, Classics in Total Sinth
gies, Method.$, VCH, Weinheim, 1996.
[2] Comprehensive Organic Spnthesis, Vol. 1-8 (Eds.: B. M Trost. I. Fleming),
Pergamon, Oxford, 1991.
[3] Encyclopedia of Reagenrs for Orgunw C/remi.s~r? ( E d . : L. A. Paquette).
Wiley. New York. 1995.
[4] E. J. Corey. X.-M. Cheng. The Logic of Chemical Synrhesi\. Wiley. New York.
1989.
[S] K. F. McClure. S . J. Danishefsky, .
I
Am. Chem. Soc. 1993. 115, 6094-6100.
[6] J. M. Schkeryantz. S . J. Danishefsky, J. Am. Chem. Soic 1995. 117. 4722-
6. Outlook
The continuous development of new protecting group techniques over the last decades resulted in most of the strategies
discussed in this review and has contributed substantially to the
impressive achievements in organic synthesis today. The successful applications of the silyl and ally1 protecting groups in
complex syntheses are particularly good examples. The authors
are of the opinion that the potential of biocatalysts is equally
vast. Basic methods relying on these systems have been developed in many areas and all that is lacking is definitive proof of
their performance in demanding synthesis.
An,?tw Chiwf. lnr E d EngI. 1996, 35. 2056-2083
4723.
[7] J. J. Masters, J. T. Link. L. B. Snyder, W. B. Young. S. J. Danishefsky, Angeir.
Chem. 1995. 107. 1886-1888; Angew. Chern. In!. Ed. EngI. 1995. 34. 17231726.
[XI Peptide and nucieotide chemistry are, however, exceptions The most advantageous combinations of protecting groups and strategies for the synthesis of
oligopeptides and oligonucleotides have often been commented on in the
relevant publications and textbooks (for examples see Schemes 35 and 52).
Because the types of functions requiring protection in these classes of compounds is limited and the number of reactions to be carried out is restricted,
the problem IS more easily defined in this area of synthesis than in the stereoselective synthesis of a complex natural product. For discussions of protecting
group strategy in peptide synthesis see for examples refs. [35, 371, and references therein, or J. Jones, The Chemical Svnrhrsis of Pi,ptii/cs, Clarendon,
Oxford. 1992; Meihod in Moleculur Eiolog!, Vol 35 P q t i d e Synrhesis
Prorocols (Eds.. M. W. Pennington. B. M. Dunn). Humana Press, Totowa,
Scimcc,) 1994. 37,
NJ (USA), 1994: S. Sakakibara. 5iopolymer.s lPepIid~~
17-28.
191 T. W. Greene, P. G. M. Wuts, Prorrcriw Groirps in Orgunrc Cliemrsrry,
2nded.. Wiley, New York, 1991.
[lo] P. J. Kocienski. Prorecring Groups. 1st ed., Thieme, Stuttgart, 1994.
[ l l ] H. Kunz. H. Waldmann in Comprehensive Organic Synrhe.si.s, Vol. 6 (Eds.:
B. M. Trost. I. Fleming, E. Winterfeldt). Pergamon, Oxford, 1991. pp. 631 701.
[I21 In the introduction in ref. [9] the choice of protecting groups in the total
synthesis of palytoxin by Kishi et al. [77] is discussed (see also Section 3.3).
The synthesis of dihydroerythronolide by R. W. Hoffmann et al (R. Stiirmer,
K. Ritter. R. W. Hoffmann, Angen Chem. 1993. 105, 112- 114; Angew Chem.
h r . Ed. Engl. 1993.32, 101-103) was also analyzed from this point ofview in
ref. [lo].
.
3775-3778.
[13] E. J. Corey. J. W Suggs, Tetrahedron L ~ I I1975.
[14] S. V. Ley, M. Woods, A. Zanossi-Gerosa, Svnrhe.si.5 1992. 52-54.
[lS] a) S . V. Ley, H. M. W. Priepke, S. L. Warriner, Angel!. Chem. 1994, 106,
2410-2412; Angew Chew. In:. Ed Engl. 1994. 33. 2290, b) S.V. Ley,
H. M. W Priepke, ihid. 1994. 106, 2412-2414 and 1994. 33. 2292.
f161 C. Riicker. Chern. Rev. 1995. 95, 1009-1064
[171 E. J. Corey, R . K. Varma. ./. Am. Chem. Soc. 1971, 93. 7319 7320.
208 1
REVIEWS
(181 K. K. Ogilvie, E. A. Thompson, M. A. Quilliam, J. B. Westinore. Gtru/tlcdron
Lett. 1974. 2865-2868.
[19] K. Toshima, S. Mukaiyama. M. Kinoshtta, K. Tatsuta. E,rruhchwi Lett
1989,30.6413-6416
[20] S. Djuric, J. Venit, P. Magnus. Tetrahedron Leu. 1981. 22, 1787-1790. R. P
Bonar-Law, A. P. Davis, B. J. Dorgan, ihid 1990. 31, 6721 -6728.
(211 a) H.Waldmdnn, D. Sebastian, Chem. R P Y .1994. Y4.911-937; b) A. Reidel.
H. Wdldmann. J Prukt. Chem. 1993, 335, 109-127; c) T. Pohl, E. Nigele.
H. Waldmann, Coru/i.sis T o d q 1994. 22. 407-426; d ) H. Waldmann in 122).
Vol. 2, pp. 851 -886.
[22] Enzjnte Cura(v.si.s in Organic Clicmisrrj (Eds: K. Drauz. H. Waldmann),
VCH. Weinheim. 1995.
[23] H. Wdldmann. Tetruhedron Lelt. 1988. 29. 1131 -1 134; Liebigs Ann. Cltem.
1988, 1175-1180.
[24] H. Wdldmdnn. E. Nigele. Angew. Cliem. 1995, 107, 2425 2428. Angeir.
Chem. Inr. Ed. Engl. 1995. 34, 2259-2262.
1251 a) P. Braun, H. Waldmdnn, W. Vogt, H. Kunz. Sj/tlerr 1990. 105-107:
b) Liehigs Ann. Cltem. 1991, 165-170.
[26] M. Schelhaas, S. Glomsdd. M. Hinder, H.-D. Jakubke, H. Waldmann,
A n g w . Chem. 1996, 108, 82-85; Angew. Chem. Inr. E d Engl. 1996, 35. 106 109.
127) H. Kunz, D. Kowalczyk, P. Braun. Angei~. C h n . 1994. 106, 353-355:
Angels. Chen. I n l . Ed. Engl. 1994, 33, 336-339.
1281 a) P. Fugedi, A. Liprdk. P. Nanasi. Curbohvdr. Rrs. 1982. 104. 55-67, b) P. J.
Garegg, H . Hultberg, S. Wallin, ibid. 1982. 108, 97-101
1291 a) G. Barany. R. B. Merrifield, J Am. Cheni. Soc. 1977, 99.7363-7365: b) E.
Meinjohanns. M. Meldal, H. Paulsen. K. Bock. 1 Cliem. Soc. Perkin Triins. 1
1995. 405-415.
[30J J. A. Barltrop, P. J. Plant. P. Schofield, Chem. Commun. 1966, X22-823.
[31] a) J. C. Sheehdn, R. M. Wilson, A. W. J. Oxford, J. A m C/tem. Soc. 1971. 93,
7222-7728; b) R. S. Givens, Ph. S. Athey. B. Matuszewski. L. W. Kueper 111.
J.-Y. Xue, T. Fister. hid. 1993, f15. 6001-6012.
[32] M C. Pirrung, Y. R. Lee, J. Org. Cliem. 1993, 58, 6961 -6963.
1331 a) A. T. Tesser, 1. C Bahert-Geers. In,. J Pepf. Prorein Res. 1975. 7.295-305:
b) G. G . J. Verhart, G . I. Tesser, Reel. Trav. Chini. Paw-Bas 1988. 107. 621 626.
[34] a) F. Nakatsubo, T. Fukuyama. A. 3. Cocuzzd. Y. Kishi, J. Am. Chent. Sor.
1977, 99, 8115-8116; b) Terruhedron Left. 1977,4295-4298.
1351 J. Rudinger. Pure Appl. Clteni. 1963, 7,335-362; recent review: M. Patek, Inr.
J Pepr. Protein Res. 1993, 42. 97-117.
(361 M. T Reetz. M. W. Drewes, A. Schinitz. Angeic. Chem. 1987, 99. 1186- 1188;
Angerr.. Chem. Inr. Ed. Engl. 1987. 26. 1141-1143.
[37] R. B. Merrifield, Pepl., Proc.. Am. Pepr. S.ymp., 5rh 1977. 488.
[38] a) R. C. Kelly. I. Gebhard, N. Wicnienski. J Or:. Chem. 1986. Sf. 45904594; b) G . R. Pettit, Y. Kamano, C. W. Holzdpfel. W. J. van Zyl. A. A. Tuinman, C. L. Herald, L. Baczynskyj, J. M. Schmidt. J A m Chem. Soc. 1987,
109, 7581 -7582.
[39] R. Windmuller. R. R. Schmidt, Tetrahedron Lert. 1994. 35, 7927-7930.
[40] H. Kunz, C. Unverzagt. Angeir. Cliem. 1988, 100. 1763 - 1765; Angeit.. Chem.
Int. Ed. Engl. 1988. 27. 1697- 1699.
[41] M. Nakatsuka, J. A. Ragan, T. Sammakia. D. B. Smith, D E. Uehling, S. L.
Schreiber, J Am. C/tem. Soc. 1990, 112, 5583-5601.
(421 a) A. D. Piscopio, N. Minowa. T. K . Chakraborty, K. Koide. P. Bertinato,
K. C. Nicolaou, J Chem. Soc. Chem. Commun. 1993, 617-618; ibid. 1993,
619-622; b) K. C. Nicolaou. T. K. Chakraborty, A. D. Piscopio, N. Minowa.
P. Bertinato, J. Am. Chem. So<. 1993, 115, 4419-4420.
1431 H. Kunz. H . Waldmann. Angels. Chem. 198597,885-887; Angeii'. Chem. lnr.
Ed. Engl. 1985, 24, 883-885.
(441 C. M. Hayward, D. Yohannes. S. J. Danishefski, 1 Am. Ciimi. Suc. 1993, /IS,
9345-9346.
[451 Y. Hayakawa. S. Wdkabayashi. H. Kato, R. Noyori, J. An?. Chem Soc. 1990.
112. 1691 -1696.
1461 S. Blechert, A. Kleine-Klausing, Angew. CItem. 1991, 103, 428-429; Angeit.
C/iem. Inr. Ed Engl. 1991, 30. 412-414.
1471 D . A. Evans, J. A. Ellman, K . M . DeVries. J. A m . Chem. Soc. 1989. ffi,
8912-8914.
[48] P. Braun, H. Waldmann. H. Kunz, S d e t r 1992. 39-40; Bionrg. Med. Cliem.
1993, 1 , 197-207.
[49] T Pohl. H. Waldmann, Angew. Chent. 1996, 108. 1829-1832, A n g w . Chem.
Inr. Ed. Engl. 1996, 35. 1720-1723.
[SO] H. Kunz, An'qew. Chem. 1987, 99, 297-311; Angew. Clieni. In/. Ed. EngI.
1987,26,294-308.
2082
4724.
(871 a) D. R. Mootoo, P. Konradsson, U. Udodong. B. Fraser-Reid. J A m . Chem.
Soc. 1988, 110, 5583-5584: b) B. Fraser-Reid, U. E. Udodong, 2. Wu. H.
Ottoson. R. Merrit. C. S. Rao. C. Roberts. Svnlert 1992. 927-942.
1881 A. Toepfer, W. Kinzy, R. R. Schmidt, Liebigs Ann. Cltem. 1994, 449-464.
[89] R. G . Denkewalter. D. E Veber. F. W. Holly, R. Hirschmann, J A m . Chrm.
Soc. 1969. 91. 502 --503.
1901 a ) E. Wunsch. G . Wendlberger. Chem. Ber. 1968, 101,341 -345, b) ihid. 1968.
101, 3659-3663.
1911 a) S. Knapp. J. J. Hale. M. Bastos, F. S. Gibson, Tcrrahedron LeIr. 1990, 31,
2109-2112; b)S. Knapp, J. J. Hale. M. Bast0s.A. Molina, K. Y Chen.J Org.
C/iem. 1992. 57. 6239-6256.
REVIEWS
Time is money...
Save both by starting a personal subscription
to Angewandte Chemie
(now with Chemistry - A ,European Journal).
At 9e per page you can't go wrong.
With your own private copy you can read the
"hot" articles before they cool, and waste
less time in front of the copier.
Order now!
An order form can be found on
the last page of this issue.
L
2083